347 related articles for article (PubMed ID: 32743954)
1. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
[TBL] [Abstract][Full Text] [Related]
2. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
Carbone F; Van den Houte K; Clevers E; Andrews CN; Papathanasopoulos A; Holvoet L; Van Oudenhove L; Caenepeel P; Arts J; Vanuytsel T; Tack J
Am J Gastroenterol; 2019 Aug; 114(8):1265-1274. PubMed ID: 31295161
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
4. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
[TBL] [Abstract][Full Text] [Related]
5. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
[TBL] [Abstract][Full Text] [Related]
8. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.
Ejskjaer N; Wo JM; Esfandyari T; Mazen Jamal M; Dimcevski G; Tarnow L; Malik RA; Hellström PM; Mondou E; Quinn J; Rousseau F; McCallum RW
Neurogastroenterol Motil; 2013 Feb; 25(2):e140-50. PubMed ID: 23279217
[TBL] [Abstract][Full Text] [Related]
9. A case report of prucalopride treatment in pediatric gastroparesis: a novel therapy.
Escobar-Serna DP; Peralta-Palmezano FJ; Peralta-Palmezano JJ
Arch Argent Pediatr; 2022 Apr; 120(2):e98-e101. PubMed ID: 35338825
[TBL] [Abstract][Full Text] [Related]
10. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
[TBL] [Abstract][Full Text] [Related]
11. Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects.
Kessing BF; Smout AJ; Bennink RJ; Kraaijpoel N; Oors JM; Bredenoord AJ
Neurogastroenterol Motil; 2014 Aug; 26(8):1079-86. PubMed ID: 24891067
[TBL] [Abstract][Full Text] [Related]
12. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
Talley NJ; Verlinden M; Geenen DJ; Hogan RB; Riff D; McCallum RW; Mack RJ
Gut; 2001 Sep; 49(3):395-401. PubMed ID: 11511562
[TBL] [Abstract][Full Text] [Related]
13. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
[TBL] [Abstract][Full Text] [Related]
14. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis.
Wang CP; Kao CH; Chen WK; Lo WY; Hsieh CL
J Altern Complement Med; 2008 Sep; 14(7):833-9. PubMed ID: 18721079
[TBL] [Abstract][Full Text] [Related]
15. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic Gastric Food Retention in Relation to Scintigraphic Gastric Emptying Delays and Clinical Factors.
Coleski R; Baker JR; Hasler WL
Dig Dis Sci; 2016 Sep; 61(9):2593-601. PubMed ID: 27193562
[TBL] [Abstract][Full Text] [Related]
17. Abdominal Pain in Patients with Gastroparesis: Associations with Gastroparesis Symptoms, Etiology of Gastroparesis, Gastric Emptying, Somatization, and Quality of Life.
Parkman HP; Wilson LA; Hasler WL; McCallum RW; Sarosiek I; Koch KL; Abell TL; Schey R; Kuo B; Snape WJ; Nguyen L; Farrugia G; Grover M; Clarke J; Miriel L; Tonascia J; Hamilton F; Pasricha PJ
Dig Dis Sci; 2019 Aug; 64(8):2242-2255. PubMed ID: 30852767
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying].
Portincasa P; Mearin F; Robert M; Plazas MJ; Mas M; Heras J
Gastroenterol Hepatol; 2009 Dec; 32(10):669-76. PubMed ID: 19819042
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A
Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis.
Abell TL; Kuo B; Esfandyari T; Pfeifer ND; Grimaldi M; Renzulli C; Tacchi R; Zhou K; Barnes CN; Nguyen DD; Nguyen L; Talley NJ; McCallum R
Neurogastroenterol Motil; 2023 Apr; 35(4):e14523. PubMed ID: 36624727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
